Bronchiolitis obliterans with organizing pneumonia associated with scleroderma and scleroderma spectrum diseases

Journal of Clinical Rheumatology

Volumn 9, Issue 4, 2003, Pages 239-245

  Taylor, J Grant ^b   Bolster, Marcy B ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BRONCHIOLITIS; CASE REPORT; COMORBIDITY; FEMALE; HUMAN; LUNG ALVEOLITIS; LUNG BIOPSY; LUNG LAVAGE; MALE; MIXED CONNECTIVE TISSUE DISEASE; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; SCLERODERMA; SPIROMETRY; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

EID: 0041571892     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000083860.27509.f1     Document Type: Article

References (17)

1. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis - a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46:428-440.
2. Ungerer RG, Tashkin DP, Furst D, et al. Prevfalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 1983;75:65-74.
3. Kallenbach J, Prinsloo I, Zwi S. Progressive systemic sclerosis complicated by diffuse pulmonary haemorrhage. Thorax. 1977;32:767-770.
4. Nishi K, Myou S, Ooka T, et al. Diffuse cutaneous systemic sclerosis associated with pan-serositis, disseminated intravascular coagulation and diffuse alveolar haemorrhage. Resp Med. 1994;88:471-473.
5. Kumagai Y, Yamagata J, Mamamoto T, et al. An autopsy case report of progressive systemic sclerosis associated with rapidly progressive glomerulonephritis and diffuse intra-alveolar hemorrhage. The Ryumachi. 1983;23:212-220.
6. Bridges AJ, Hsu K, Dias-Arias AA, et al. Bronchiolitis obliterans organizing pneumonia and Scleroderma. J Rheum. 1992;19:1346-1340.
7. Davidson AG, Epstein O. Relapsing organizing pneumonitis in a man with primary biliary cirrhosis, CREST syndrome, and chronic pancreatitis. Thorax. 1983;38:316-317.
8. Maricq HR. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma. Arch of Derm. 1992;128: 630-632.
9. Izumi T. The global view of idiopathic bronchciolitis obliterans organizing pneumonia. In: Epler GR (ed.), Diseases of the Bronchioles. New York: Raven Press, 1994;307-312.
10. Fishman AP, et al. Pulmonary Diseases and Disorders: Occupational Pulmonary Diseases, Part 1, Interstitial Diseases. In: Fishman AP (ed.), New York: McGraw-Hill, 1988;840-842.
11. Warrick JH, Bhalla M, Schabel SI, et al. High resolution computed tomography in early Scleroderma lung disease. J Rheum. 1991;18:1520-1528.
12. Silver RM, Metcalf JF, Stanley JH, et al. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984;27:1254-1262.
13. Silver RM, Warrick JH, Kinsella MB, et al. Cyclophosphamide and low dose prednisone therapy in patients with systemic sclerosis with interstitial lung disease. J Rheum. 1993;20:838-844.
14. Steen VD, Lanz JK, Conte C, et al. Therapy for severe interstitial lung disease in systemic sclerosis: a retrospective study. Arthritis Rheum. 1994;37: 1290-1296.
15. Akesson A. Cyclophosphamide therapy for scleroderma. Curr Opin Rheum. 1998;10:579-583.
16. Behr J, Vogelmeier C, Beinert T, et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med. 1996;154:400-406.
17. Steen VD, Medsger TA Jr. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthitis Rheum. 1998;41:1613-1619.